Live Breaking News & Updates on Marc voigt

Stay informed with the latest breaking news from Marc voigt on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Marc voigt and stay connected to the pulse of your community

Individual investors account for 60% of Immutep Limited's (ASX:IMM) ownership, while institutions account for 29%

Key Insights Immutep's significant individual investors ownership suggests that the key decisions are influenced by...

Marc-voigt , Regal-partners , Partners-limited ,

Immutep Limited (IMMP) Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer

Immutep Limited (IMMP) Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Germany , German , Marc-voigt , Immutep-limited , Committee-for-medicinal-products-human-use , Nasdaq , Drug-administration , Medicinal-products , Human-use ,

Biotech stocks weather down market; showing solid signs of recovery

It’s been a difficult quarter for the biotech sector, with economies struggling to recover from high inflation making for a small appetite for risk. The ASX...

Sydney , New-south-wales , Australia , Georgia , California , United-states , Canada , Syracuse , New-york , Tbilisi , Georgia-general-

Immutep to Participate in November Investor Events

Immutep to Participate in November Investor Events
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Australia , Sydney , New-south-wales , Australian , Chris-basta , Wade-iams , Marc-voigt , Christian-mueller , Frederic-triebel , Nasdaq , Immutep-limited , Corporate-communications

Immutep's Efti Proves Effective Combined with MSD's Pembrolizumab

Immutep's Efti Proves Effective Combined with MSD's Pembrolizumab
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Australia , Spain , Australian , Marc-voigt , Enric-carcereny , Catalan-institute-of-oncology , Catalan-institute ,

Immutep Shares Jump 13% on Lung-Cancer Combination Trial Data

By Stuart Condie SYDNEY--Immutep shares are on course for their best day since June after the Australia-listed developer of cancer treatments presented...

Sydney , New-south-wales , Australia , Australian , Stuart-condie , Marc-voigt , Merck-co , Chief-executive-marc-voigt , Article-normal , Biotechnology-services , Pharmaceuticals , Cancer-drugs

Immutep's Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer

Media Release Median Overall Survival reaches 35.5 months in first-line treatment of metastatic non-small cell lung cancer patients expressing PD-L1 (TPS >1%), 23.4 months in patients with low PD-L1 expression (TPS 1-49%), and has not been reached in patients with high PD-L1 expression (TPS >50%), exceeding expectationsPromising Overall Survival, Overall Response Rate, Progression Free Survival, and Duration of Response visible across all PD-L1 subgroups (TPS <1%, ≥1%, 1-49%, and ≥50%), differen

Badalona , Comunidad-autonoma-de-cataluna , Spain , Australia , United-states , Sydney , New-south-wales , Australian , Frederic-triebel , Christian-mueller , Florian-vogl , Marc-voigt

Immutep Announces Publication of Abstracts at ESMO Congress 2023

Media ReleaseNew updated data from TACTI-002, including more mature Overall Survival data, will be presented during the Mini Oral session on Satur...

Australia , Sydney , New-south-wales , United-states , Frankfurt , Brandenburg , Germany , Australian , Enric-carcereny , Chris-basta , Florian-vogl , Katarzyna-kozak

Commercial Manufacturing of Eftilagimod Alpha at 2000L Scale Granted Authorization for Clinical Trial Use

Commercial Manufacturing of Eftilagimod Alpha at 2000L Scale Granted Authorization for Clinical Trial Use
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , United-kingdom , Germany , Australia , Denmark , Sydney , New-south-wales , Belgium , Australian , Chris-basta , Marc-voigt , Drug-administration

With 49% stake, Immutep Limited (ASX:IMM) seems to have captured institutional investors' interest

Key Insights Significantly high institutional ownership implies Immutep's stock price is sensitive to their trading...

Marc-voigt , Fidelity-international-ltd , Milford-asset-management , Asset-management ,